Dare BioscienceDARE
13F holders, Q2 2024 (June 30)24holders −12
3new positions
15sold out
1famous investor
$0.34avg. 13F price*
At the end of Q2 2024, 24 institutions reported holding Dare Bioscience Inc. (DARE) in their 13F filings, down 12 from Q1 2024. 3 opened new positions and 15 sold out. The largest holders were Vanguard Group Inc. ($1.1M), Geode Capital Management, LLC ($371K) and AMH Equity Ltd ($310K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Dare Bioscience Inc.
- CUSIP
- 23666P101
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $314K |
| Exits | 15 | $258K |
All 13F filers, Q1 2024 → Q2 2024: 1,184,951 shares bought and 819,048 shares sold, net +365,903 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | Reduce -2.7% | 3,358,215 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +1.7% | 1,006,561 | $371K |
| AMH Equity Ltd | 0.46% | New | 923,619 | $310K |
| Renaissance Technologies | 0.00% | Add +2.1% | 778,700 | $262K |
| State Street Corp. | 0.00% | Add +13.9% | 282,210 | $95K |
| BlackRock Inc. | 0.00% | Reduce -48.6% | 203,632 | $68K |
| Northern Trust Corp. | 0.00% | Add +1.2% | 185,485 | $62K |
| Two Sigma Securities, LLC | 0.00% | Add +209.1% | 102,896 | $35K |
| UBS Group AG | 0.00% | Add +19703.2% | 99,016 | $33K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 45,925 | $15K |
| Susquehanna International Group, LLP | 0.00% | Add +32.8% | 34,958 | $12K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 30,875 | $10K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 30,532 | $10K |
| Bank of New York Mellon Corp | 0.00% | Add +13.1% | 25,947 | $9K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | No change | 20,000 | $7K |
| Osaic Holdings, Inc. | 0.00% | No change | 20,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -24.6% | 15,302 | $5K |
| Jane Street Group, LLC | 0.00% | Reduce -5.2% | 11,145 | $4K |
| Cerity Partners LLC | 0.00% | New | 10,000 | $3K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -31.8% | 3,000 | $1K |
| Mather Group, Llc. | 0.00% | New | 1,000 | $490 |
| Bank of America Corp. | 0.00% | Add +571.9% | 981 | $330 |
| FMR LLC | 0.00% | Reduce -53.3% | 503 | $169 |
| JPMorgan Chase & Co. | 0.00% | Add +4.2% | 249 | $84 |
"% of holder's portfolio" is DARE's weight in each manager's 13F, not the share of Dare Bioscience Inc. the manager owns.